MedPath

Confirmatory study of TRK-820 Soft Capsules

Phase 3
Conditions
Intractable Pruritus in Patients With Chronic Liver Disease
Registration Number
JPRN-jRCT2080221261
Lead Sponsor
Toray Industries,Inc.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Chronic Liver Disease
It can be confirmed that the treatment of pruritus with antihistamines or antiallergics has not been adequately effective in such patients.

Exclusion Criteria

Malignant tumors except for early-stage hepatocellular carcinoma
Allergy to opioid drugs

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath